CenterBook Partners’s Halozyme HALO Stock Holding History

CenterBook Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,707	Closed	-$1.29M	–	444
2023 Q1	$1.29M	Buy	33,707 +20,391	+153%	+$956K	0.18%	182
2022 Q4	$758K	Sell	13,316 -6,615	-33%	-$339K	0.12%	241
2022 Q3	$788K	Buy	19,931 +9,843	+98%	+$435K	0.15%	225
2022 Q2	$444K	Sell	10,088 -10,026	-50%	-$434K	0.1%	282
2022 Q1	$802K	Buy	20,114 +7,288	+57%	+$260K	0.29%	125
2021 Q4	$516K	Buy	+12,826	New	+$479K	0.3%	131

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CenterBook Partners's HALO Position: Q2 2023 in Review

CenterBook Partners sold out of Halozyme (HALO) in Q2 2023, closing a stake of 33,707 shares — an estimated $1.29M sold.

CenterBook Partners first reported a position in HALO in Q4 2021 and held it in 6 quarters. The position peaked at $1.29M in Q1 2023. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

CenterBook Partners reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
CenterBook Partners sold 33,707 Halozyme shares in Q2 2023, an estimated $1.29M.
CenterBook Partners first reported a position in Halozyme in Q4 2021 and held it in 6 quarters.
CenterBook Partners's Halozyme position peaked at $1.29M in Q1 2023.
370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on CenterBook Partners's 13F filing for Q2 2023, filed 14 Aug 2023.